Pregled bibliografske jedinice broj: 1186958
Antiplatelet usage alters clot density in acute ischemic stroke: A hyperdense middle cerebral artery study
Antiplatelet usage alters clot density in acute ischemic stroke: A hyperdense middle cerebral artery study // European Journal of Neurology, 24 (Suppl. 1), 123– 444
Amsterdam, Nizozemska, 2017. str. 362-362 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1186958 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antiplatelet usage alters clot density in acute
ischemic stroke: A hyperdense middle cerebral
artery study
Autori
Pikija, Slaven ; Magdic, Jozef ; Lukić, Anita ; Schreiber, Catharina ; Mutzenbach, Johannes Sebastian ; McCoy, Mark R ; Sellner, Johann
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Neurology, 24 (Suppl. 1), 123– 444
/ - , 2017, 362-362
Skup
3rd Congress of the European Academy of Neurology, Amsterdam, The Netherlands, June 2017
Mjesto i datum
Amsterdam, Nizozemska, 24.06.2017. - 27.06.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
ischemic stroke, hyperdense artery sign, antiplatelets, computed tomography, clot
Sažetak
Background and aims: The hyperdense artery sign on computed tomography is a surrogate of intraluminal thrombus. Clot density can be quantified by means of Hounsfield Units (HU). Here, we explored whether clot density in middle cerebral artery (MCA) occlusion is related to blood constituents and prestroke medication. Methods: We performed a retrospective review of patients with ischemic stroke admitted within 4.5 h of symptom onset. We assessed the site of MCA occlusion as well as density of the clot in 150 patients. The HU values for the clot were divided with contralateral MCA segment to yield relative HU ratio (rHU). Results: We found an inverse correlation of rHU with erythrocyte count (p<0.001). Patients on antiplatelets had a significantly higher rHU compared to patients without (p=0.024). Higher rHU was more likely with the use of antiplatelets (OR 4.24, CI 1.10-16.31, p=0.036). Erythrocyte (OR 0.18, CI 0.05-0.55, p=0.003), and thrombocyte counts (OR 0.99, CI 0.98-0.99, p=0.029) were associated with odds for more hypodense clots. Conclusion: Aspirin alters clot structure in vitro, resulting in the formation of clots with thicker fibbers and bigger pores, which subsequently allows better entanglement of erythrocytes and raises the efficacy of thrombolysis. Our study disclosed an effect of antiplatelet therapy on the composition of intracranial clots in the setting of acute ischemic stroke in the anterior circulation. This finding may in part explain the higher success of thrombolyis and better prognosis ischemic stroke in patients on aspirin.Disclosure: Nothing to disclose
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE